Correlagen to Launch Genetic Cardiovascular Disease Assay on Helicos Platform This Month

genomeweb -- Genetic testing company Correlagen Diagnostics plans to launch a comprehensive assay for genetic cardiovascular disease this month that will run on a Helicos BioSciences' sequencing platform in its CLIA lab, In Sequence has learned.